These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 25118276)
1. KLRG+ invariant natural killer T cells are long-lived effectors. Shimizu K; Sato Y; Shinga J; Watanabe T; Endo T; Asakura M; Yamasaki S; Kawahara K; Kinjo Y; Kitamura H; Watarai H; Ishii Y; Tsuji M; Taniguchi M; Ohara O; Fujii S Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12474-9. PubMed ID: 25118276 [TBL] [Abstract][Full Text] [Related]
2. Eomes transcription factor is required for the development and differentiation of invariant NKT cells. Shimizu K; Sato Y; Kawamura M; Nakazato H; Watanabe T; Ohara O; Fujii SI Commun Biol; 2019; 2():150. PubMed ID: 31044175 [TBL] [Abstract][Full Text] [Related]
3. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Ota T; Takeda K; Akiba H; Hayakawa Y; Ogasawara K; Ikarashi Y; Miyake S; Wakasugi H; Yamamura T; Kronenberg M; Raulet DH; Kinoshita K; Yagita H; Smyth MJ; Okumura K Blood; 2005 Jul; 106(1):184-92. PubMed ID: 15746081 [TBL] [Abstract][Full Text] [Related]
4. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses. Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977 [TBL] [Abstract][Full Text] [Related]
6. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles. Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695 [TBL] [Abstract][Full Text] [Related]
7. Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ. Sakurai T; Inamine A; Iinuma T; Funakoshi U; Yonekura S; Sakurai D; Hanazawa T; Nakayama T; Ishii Y; Okamoto Y Clin Exp Immunol; 2014 Oct; 178(1):65-74. PubMed ID: 24943738 [TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes. Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368 [TBL] [Abstract][Full Text] [Related]
9. Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets. Leborgne NGF; Taddeo A; Freigang S; Benarafa C Front Immunol; 2020; 11():562587. PubMed ID: 33262755 [TBL] [Abstract][Full Text] [Related]
10. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma. Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885 [TBL] [Abstract][Full Text] [Related]
11. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913 [TBL] [Abstract][Full Text] [Related]
12. Rapid and reliable generation of invariant natural killer T-cell lines in vitro. Chiba A; Cohen N; Brigl M; Brennan PJ; Besra GS; Brenner MB Immunology; 2009 Nov; 128(3):324-33. PubMed ID: 20067532 [TBL] [Abstract][Full Text] [Related]
13. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells. Lawson V Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667 [TBL] [Abstract][Full Text] [Related]
14. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925 [TBL] [Abstract][Full Text] [Related]
15. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells. Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431 [TBL] [Abstract][Full Text] [Related]
16. The presence of CD8+ invariant NKT cells in mice. Lee H; Hong C; Shin J; Oh S; Jung S; Park YK; Hong S; Lee GR; Park SH Exp Mol Med; 2009 Dec; 41(12):866-72. PubMed ID: 19745607 [TBL] [Abstract][Full Text] [Related]
17. Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production. Matsuda H; Takeda K; Koya T; Okamoto M; Shiraishi Y; Miyahara N; Dakhama A; Matsuda JL; Gapin L; Gelfand EW J Immunol; 2010 Jul; 185(1):253-62. PubMed ID: 20525882 [TBL] [Abstract][Full Text] [Related]
18. The mechanism of splenic invariant NKT cell activation dictates localization in vivo. King IL; Amiel E; Tighe M; Mohrs K; Veerapen N; Besra G; Mohrs M; Leadbetter EA J Immunol; 2013 Jul; 191(2):572-82. PubMed ID: 23785119 [TBL] [Abstract][Full Text] [Related]
19. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells. Yang G; Artiaga BL; Lewis ST; Driver JP Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168 [TBL] [Abstract][Full Text] [Related]